Newsroom

Filters: 2021
x

Twitter

Videos

Photos

20160128 EGA Regulatory and Scientific Affairs Conferenc

Digitalisation the key to efficient EU pharmaceutical regulation and easing of localised drug shortages

27 October 2021

“Digitalisation the key to efficient EU pharmaceutical regulation and easing […]

Read more

“Central Role For Industry Beckons As Europe Rebuilds After COVID” – Interview to Rebecca Guntern

25 October 2021

Generics And Biosimilars Must Become A Central Policy Pillar, Says […]

Read more

Smart use of off-patent medicines will be critical to rebuild healthcare systems successfully post-Covid

7 October 2021

Open

Baton passes from Christoph Stoller to Rebecca Guntern as President of Medicines for Europe

1 October 2021

Rebecca Guntern (Sandoz) today begins an interim term as President […]

Read more

HERA must address outstanding weaknesses in EU pharma framework to be successful

16 September 2021

Medicines For Europe strongly supports the EU’s drive to learn from COVID-19 […]

Read more

Arun Narayan, Chairman of the Value Added Medicines Sector Group interviewed by the European Pharmaceutical review

8 September 2021

Open

EU must take the lead to ensure security of supply for medicines

16 June 2021

Legislative reforms aligned with current off-patent market conditions are the […]

Read more

EU Industry Welcomes New Schengen Strategy’s Green Lanes

4 June 2021

“EU Industry Welcomes New Schengen Strategy’s Green Lanes” Read more

Read more

Opinion piece by Christoph Stoller for Friends of Europe

3 June 2021

“Too much at stake in the EU pharma strategy to […]

Read more

Open borders that prioritise essential goods key to medicines supply in Europe

2 June 2021

Open

Subscribe to our newsletter